NANDROLONE PHENPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nandrolone Phenpropionate, and what generic alternatives are available?
Nandrolone Phenpropionate is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in NANDROLONE PHENPROPIONATE is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NANDROLONE PHENPROPIONATE?
- What are the global sales for NANDROLONE PHENPROPIONATE?
- What is Average Wholesale Price for NANDROLONE PHENPROPIONATE?
Summary for NANDROLONE PHENPROPIONATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Patent Applications: | 4,255 |
| DailyMed Link: | NANDROLONE PHENPROPIONATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NANDROLONE PHENPROPIONATE
US Patents and Regulatory Information for NANDROLONE PHENPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 086386-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 087488-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
